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PCarbon Monoxide Poisoning
ardiovascular Manifestations of
oderate to Severe Carbon Monoxide Poisoning
aniel Satran, MD,* Christopher R. Henry, BS,† Cheryl Adkinson, MD,‡ Caren I. Nicholson, RN,‡
iscah Bracha, MS,‡ Timothy D. Henry, MD†
inneapolis, Minnesota
OBJECTIVES We describe the cardiovascular manifestations of carbon monoxide (CO) poisoning.
BACKGROUND Carbon monoxide poisoning is a common cause of toxicologic morbidity and mortality.
Although the neurologic sequelae of CO poisoning have been well described, the cardiovas-
cular consequences are limited to isolated case reports.
METHODS We reviewed the cardiovascular manifestations of 230 consecutive patients treated for
moderate to severe CO poisoning in the hyperbaric oxygen chamber at Hennepin County
Medical Center (HCMC), a regional center for treatment of CO poisoning.
RESULTS The mean age was 47.2 years with 72% men. Ischemic electrocardiogram (ECG) changes
were present in 30% of patients, whereas only 16% had a normal ECG. Cardiac biomarkers
(creatine kinase-MB fraction or troponin I) were elevated in 35% of patients. In-hospital
mortality was 5%.
CONCLUSIONS Cardiovascular sequelae of CO poisoning are frequent, with myocardial injury assessed by
biomarkers or ECG in 37% of patients. Patients admitted to the hospital with CO poisoning
should have a baseline ECG and serial cardiac biomarkers. (J Am Coll Cardiol 2005;45:
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.01.0441513–6) © 2005 by the American College of Cardiology Foundation
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farbon monoxide (CO) poisoning is a common cause of
oxicologic morbidity and the most common cause of death
rom poisoning in the U.S. (1). Sources of CO poisoning
nclude any source of combustion, such as faulty furnaces,
utomobile exhaust, charcoal, industrial solvents, and to-
acco smoke. The neurologic consequences of CO poison-
ng have been well described, and symptoms include head-
che, dizziness, weakness, nausea, and confusion (2,3).
owever, the cardiovascular consequences of CO poisoning
re limited to isolated case reports of ECG changes,
yocardial dysfunction, and myocardial infarction (4–20).
e describe the cardiovascular manifestations in 230 con-
ecutive patients with moderate to severe CO poisoning
reated with hyperbaric oxygen (HBO2) therapy.
ETHODS
ennepin County Medical Center (HCMC) is a Midwest
egional center for the treatment of CO poisoning. We
ollected data on 230 consecutive adult patients treated for
oderate to severe CO poisoning with HBO2 therapy at
CMC between January 1, 1994, and January 1, 2002. The
tudy was approved by the institutional review committee
nd procedures were in accordance with institutional guide-
ines.
From the *Division of Cardiology, University of Minnesota, Minneapolis, Min-
esota; †Minneapolis Heart Institute Foundation, Minneapolis, Minnesota; and
Department of Emergency Medicine, Hennepin County Medical Center, Minne-
polis, Minnesota.e
Manuscript received November 4, 2004; revised manuscript received January 19,
005, accepted January 25, 2005.Patient demographics, cardiovascular history, and cardiac
isk factors from a comprehensive HBO2 database were
erified with the medical record. Cardiac biomarker results
creatine kinase [CK], CK-MB, and cardiac troponin I)
ere obtained independently from the clinical laboratory
nd the medical record. Carboxyhemoglobin (COHb) levels
ere obtained from pre-hospital sources or at HCMC if not
vailable in the field. Glasgow Coma Scale (GCS) measure-
ents were obtained at initial pre-hospital evaluation and
pon arrival at HCMC.
Indications for HBO2, regardless of COHb level, in-
luded any history of altered consciousness, seizure, focal
eurologic deficit, ischemic chest pain, ECG changes, new
ysrhythmias or hypotension. In addition, a COHb level
40% or a COHb level of 25% plus a history of
ardiovascular disease, cerebrovascular disease, age 60,
xposure 2 h, or a hemoglobin 10 mg/dl were indica-
ions. The HBO2 protocol was one treatment for 90 min on
00% oxygen at 2.4 absolute atm. Additional treatments
ere performed for continued lethargy or unresponsiveness
15 patients).
Electrocardiograms were reviewed independently from
linical data by a cardiologist (T.H.) and were classified by
hythm and ST-T wave changes. Ischemic changes were
lassified as new ST-segment elevation (1 mm), depres-
ion (0.5 mm), or T-wave inversion 2 mm) in two
onsecutive leads. Continuous ECG monitoring was per-
ormed on intubated patients and patients with chest pain,
yspnea, or ECG changes. Echocardiograms were per-
ormed after hyperbaric treatment and were classified by
jection fraction and wall motion abnormalities.
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Cardiovascular Manifestations of CO Poisoning May 3, 2005:1513–6tatistical analysis. Univariate logistic regression models
or predictors of myocardial injury (elevated cardiac
iomarkers) were performed using chi-square tests of
ssociation for dichotomous predictive factors and t tests
o compare means for continuous predictive factors using
AS software.
ESULTS
linical characteristics (Table 1). For 230 consecutive
atients, 72% were men and the mean age was 47.2 years.
lthough 56% were active tobacco smokers, other cardiac
isk factors were uncommon, including 23% with hyperten-
ion and only 7% with diabetes. Previous history of cardio-
ascular disease was also uncommon (7% previous myocar-
ial infarction [MI] and 3% previous revascularization). The
tiology of the CO poisoning was accidental in 59% of
atients (fire exposure, furnace, space heater, stove, or
ndustrial equipment malfunction), intentional (suicide at-
empt) in 40%, and unclear in 1%.
arkers of illness severity. Glasgow Coma Scale was
bnormal (14) in 106 (46%) patients (range 3 to 15) upon
rrival at HCMC. Loss of consciousness occurred in 187
atients (81%) and 116 required intubation (50%). Lido-
aine or nitroglycerin was used in 27 patients (12%), and 14
6%) required agents for blood pressure support. The
edian number of hospital days was 3 (interquartile range
to 6).
lectrocardiograms. A baseline ECG was available for
8% of patients, of which 16% were normal. Sinus tachy-
ardia was present in 41% of patients. Diagnostic ischemic
Abbreviations and Acronyms
CAD  coronary artery disease
CO  carbon monoxide
COHb  carboxyhemoglobin
ECG  electrocardiogram
GCS  Glasgow Coma Scale
HBO2  hyperbaric oxygen
HCMC  Hennepin County Medical Center
MI  myocardial infarction
WMA  wall motion abnormality
able 1. Patient Characteristics (n  230)
ge (yrs) 47.2 (19–91)*
en 166 (72%)
iabetes 15 (7%)
ypertension 52 (23%)
ctive smoker 129 (56%)
revious myocardial infarction 15 (7%)
revious revascularization 6 (3%)
ccidental poisoning 135 (59%)
ntentional poisoning 91 (40%)
OHb level (%) 33.1 (2–65)*
ntubated 116 (50%)
equiring pressor agents 14 (6%)S
Average with range.
COHb  carboxyhemoglobin.hanges were present in 30% of patients (26% with ST- or
-wave changes and 4% with ST-segment elevation),
hereas 41% had nonspecific ST changes and 27% had no
schemic changes.
ardiac biomarkers. Of the 183 patients with cardiac
iomarkers available (80% of the total population), 81
atients (35% of the total population or 44% of patients
ith biomarkers drawn) had cardiac biomarkers diagnostic
f myocardial injury (CK-MB mass 5.0 ng/ml or cardiac
roponin I 0.7 ng/ml). An additional four patients had
CG changes diagnostic of myocardial injury, but serial
ardiac biomarkers were not available.
chocardiograms. Of the 53 patients with echocardio-
rams, 30 (57%) had abnormal LV function, including 14
ith global LV dysfunction and 16 with regional wall
otion abnormality (WMA). Right ventricular dysfunction
as present in 18 patients. The average age of patients with
egional WMA was 64 years, in contrast to 43 years in
atients with global LV dysfunction.
utcomes. In-hospital mortality was 5% (12 patients), the
ost common cause being a composite of anoxic brain
njury and burn injury (8 patients). Four patients had cardiac
rrest with anoxic brain injury and none survived. Only six
atients underwent cardiac catheterization. Three patients
ere found to have coronary artery disease (CAD) (50%
esions) and underwent coronary artery bypass grafting.
redictors of myocardial injury. Predictors of myocardial
njury included male gender, a GCS score of 14, and
ypertension (Table 2). No other patient characteristics,
ncluding age; COHb level; diabetes; family history of
AD; hyperlipidemia; cocaine use; or a history of MI,
erebrovascular disease, congestive heart failure, renal dis-
ase or revascularization, were predictive of myocardial
njury. Active cigarette smoking lowered the relative risk of
yocardial injury.
Of patients with positive biomarkers, 53% had ischemic
CG changes, and in patients with ischemic ECG changes,
4% had positive biomarkers. Of patients with echocardio-
raphic abnormalities (regional or global), 97% had positive
iomarkers.
able 2. Predictors of Myocardial Injury
No Injury Injury RR 95% CI
en 64.8 84.7 3.01 1.52–5.94
CS 14 41.7 61.5 2.23 1.27–3.94
ypertension 18.3 31.3 2.04 1.09–3.82
revious revascularization 0.7 1.2 1.74 0.11–28.16
iabetes 5.6 8.4 1.55 0.54–4.45
revious MI 6.3 7.2 1.16 0.40–3.38
ge (5 yrs) 44.8* 51.2* 1.12 1.03–1.22
OHb level (10%) 32.7† 33.9† 1.03 0.93–1.14
urrent smoker 64 48.2 0.52 0.30–0.91
olumns 1 and 2 represent percent of patients with predictor, except *average and
measured percent. 95% confidence intervals are derived from univariate logistic
egression models, where myocardial injury (yes/no) is the outcome of interest.COHb  carboxyhemoglobin; CI  confidence interval; GCS  Glasgow Coma
cale; MI  myocardial infarction; RR  relative risk.
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May 3, 2005:1513–6 Cardiovascular Manifestations of CO PoisoningISCUSSION
ur results demonstrate that myocardial injury from mod-
rate to severe CO poisoning is common, with 37% of
atients having myocardial injury assessed by ECG or
iomarkers. Myocardial injury by CK-MB or cardiac tro-
onin I elevation occurred in 35% of the total population
44% of patients with biomarkers drawn) despite a low
ncidence of significant cardiac risk factors or known CAD.
echanisms of myocardial injury with CO poisoning.
yocardial injury from CO poisoning results from tissue
ypoxia as well as damage at the cellular level. The affinity
f hemoglobin for CO is 200 to 250 times greater than its
ffinity for oxygen. This results in competitive inhibition of
xygen release due to a shift in the oxygen-hemoglobin
issociation curve, reduced oxygen delivery, and subsequent
issue hypoxia (3). In vitro, CO binds to cytochrome-c
xidase of the electron transport chain resulting in asphyx-
ation at the cellular level (21). Oxygen radical formation
nd subsequent lipid peroxidation has also been implicated
s a mechanism for cell death (21). High concentrations of
O have been shown to induce cellular apoptosis mediated
y nitric oxide (22). In preclinical models, CO poisoning in
ogs results in global as well as relative subendocardial
ypoperfusion (23).
Recently there has been interest in the potential beneficial
ffects of CO mediated by its activation of soluble guanylate
yclase similar to nitric oxidase (24). This results in vasodi-
ation, inhibition of platelet adhesion, and inhibition of
lasminogen activator inhibitior-1. It is interesting to note
hat current smoking (leading to elevated CO levels) low-
red the risk of myocardial injury in our study. However, the
eleterious effects of CO poisoning in our study population
verwhelm any potential beneficial effects of low level CO.
revious case reports. Descriptions of the cardiovascular
anifestations of CO poisoning in humans have been
imited to case reports (4–20). Colvin reported a patient
ith ECG abnormalities that ultimately normalized in 1928
5). A case series by Stearnes 10 years later documented
CG findings in 22 patients (20). Anderson described
CG findings in seven cases (including ST-segment eleva-
ion and ST-segment depression) and pathology (apical
ural thrombus and LAD thromboembolus) in one patient
4). Corya et al. (6) reported echocardiography findings in
ve patients, with variable resolution of abnormalities.
T-segment elevation MI with transmural myocardial ne-
rosis in a 28-year-old patient (8) and myocardial injury
ith normal coronary arteries have been reported as well
13,14).
yperbaric oxygen (HBO2) therapy. Hyperbaric oxygen
herapy is generally accepted as therapy for moderate to
evere CO poisoning. Indications include coma, any period
f unconsciousness, a COHb concentration of 40%, signs
f cardiac ischemia, arrhythmias, or a history of CAD and
OHb level 20%, all based on limited data (3). Hyper-
aric oxygen therapy may reduce the risk of cognitive sequelae after acute CO poisoning even for patients who do
ot meet these criteria (25).
Limited data exist regarding HBO2 therapy for preven-
ion of myocardial injury. In a series of 18 patients with
ardiac arrest who were resuscitated, outcomes were uni-
ormly fatal despite HBO2 (26). Whether HBO2 may limit
yocardial injury or infarct size without initial cardiac arrest
s unknown. In dogs, HBO2 with and without thrombo-
ytics has been shown to limit infarct size following coronary
rtery occlusion (27). Hyperbaric oxygen therapy has also
een shown to limit infarct size in ischemic rabbit hearts,
nd the effect appears to be time dependent: the earlier the
nitiation of treatment, the better the outcome (27,28).
ther investigators have shown no beneficial effect for HBO2
n infarct size in dogs (29). A small randomized trial (n 122)
f thrombolytics alone versus thrombolytics plus HBO2 dem-
nstrated a nonsignificant improvement in peak CK levels and
jection fraction with the addition of HBO2 (30).
atterns of myocardial injury. Two clinical patterns of
yocardial injury were apparent in our study. One group of
atients was younger (average age 43 years) with few cardiac
isk factors but severe CO poisoning, demonstrated by
bnormal GCS score. These patients were more likely to
ave global left ventricular dysfunction by echocardiogram,
hich improved or resolved consistent with stunned myo-
ardium as a result of CO poisoning. A second group of
atients with regional WMA was older (average age 64
ears) with a higher frequency of cardiac risk factors, and
0% had a normal GCS. In these patients, CO poisoning
ppears to unmask underlying CAD by creating supply/
emand mismatch.
In all likelihood, our results underestimate the incidence
f myocardial injury in patients with severe CO poisoning.
erial cardiac biomarkers were not available in 20% of
atients, and echocardiograms were not uniformly per-
ormed on patients who had positive CK-MB or cardiac
roponin I. On the other hand, the percent of patients with
chocardiographic abnormalities may be higher than ex-
ected because they may have been obtained in patients
ith myocardial injury. Our study focused on moderate to
everely poisoned patients referred for HBO2 and admitted
o the hospital, a higher risk cohort including some with
igns of myocardial ischemia. One study of “mild” CO
oisoning (based on CO levels) suggested no adverse cardiac
equelae, but ECG data and cardiac biomarkers were not
ncluded (31).
In conclusion, myocardial injury is common in moderate to
evere CO poisoning. A baseline ECG should be performed
nd serial biomarkers should be followed in all patients.
atients with abnormal cardiac biomarkers should have an
chocardiogram. Patients with persistent LV dysfunction, un-
erlying CAD, or risk factors for CAD may benefit from
urther evaluation including angiography and revascularization.
urther study is needed to determine the long-term clinical
ignificance of the myocardial injury as well as the efficacy of
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njury resulting from CO poisoning.
eprint requests and correspondence: Dr. Timothy D. Henry,
inneapolis Heart Institute Foundation, 920 East 28th Street, Suite
0, Minneapolis, Minnesota 55407. E-mail: henry003@umn.edu.
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